![Clayton Duncan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clayton I.
Duncan was the founder of Synereca Pharmaceuticals, Inc. since 2009, holding the title of Chairman & Chief Executive Officer.
Former jobs include Chairman, President & Chief Executive Officer at Incara Pharmaceuticals Corp., Chief Executive Officer at Entegrion, Inc., Chairman & Chief Executive Officer at Accele Biopharma, Inc. from 2011 to 2017, Chief Executive Officer at Sphinx Pharmaceuticals Corp, Chief Executive Officer at Ercole Biotech, Inc., Chief Executive Officer at Research Triangle Park, Chairman & Chief Executive Officer at Pamlico BioPharma, Inc., and Principal at Accele Venture Management LLC.
Education includes an undergraduate degree from the University of California, Santa Barbara and an MBA from The University of North Carolina at Charlotte.
| Sociétés | Poste | Fin |
|---|---|---|
Accele Biopharma, Inc.
 Accele Biopharma, Inc. Investment ManagersFinance Accele Biopharma invests in companies located in the United States. The firm focuses on broad range of sectors and industries. It provides financing for early stage capital requirements. | Directeur Général | 01/09/2017 |
Incara Pharmaceuticals Corp.
 Incara Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cardiovascular and pulmonary diseases | Directeur/Membre du Conseil | 09/08/2004 |
Pamlico BioPharma, Inc.
 Pamlico BioPharma, Inc. BiotechnologyHealth Technology Provides antibody therapeutics services | Directeur Général | - |
Sphinx Pharmaceuticals Corp
 Sphinx Pharmaceuticals Corp Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | - |
Entegrion, Inc.
 Entegrion, Inc. Pharmaceuticals: MajorHealth Technology Develops biological technologies, drugs, and pharmaceuticals | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 11 |
|---|---|
Incara Pharmaceuticals Corp.
Incara Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cardiovascular and pulmonary diseases | Health Technology |
Entegrion, Inc.
Entegrion, Inc. Pharmaceuticals: MajorHealth Technology Develops biological technologies, drugs, and pharmaceuticals | Health Technology |
Synereca Pharmaceuticals, Inc.
 Synereca Pharmaceuticals, Inc. Medical DistributorsDistribution Services Develops orally active drugs that restore the effectiveness of existing antibiotics | Distribution Services |
Accele Biopharma, Inc.
Accele Biopharma, Inc. Investment ManagersFinance Accele Biopharma invests in companies located in the United States. The firm focuses on broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Sphinx Pharmaceuticals Corp
Sphinx Pharmaceuticals Corp Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops splice switching drugs for the treatment of major human diseases | Commercial Services |
Research Triangle Park | |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accele Venture Management LLC
 Accele Venture Management LLC Investment ManagersFinance Accele Venture Management LLC invests in companies located in the US. The firm targets operating in the filed of healthcare. The firm provides financing for seed stage capital requirements. | Finance |
Pamlico BioPharma, Inc.
Pamlico BioPharma, Inc. BiotechnologyHealth Technology Provides antibody therapeutics services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
